Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
Gang Wang,1 Xiumin You,2 Xueyi Wang,3 Xiufeng Xu,4 Ludong Bai,5 Jian Xie,6 Zhijian Yao,7 QiZhong Yi,8 Jun Ma,9 Jinan Wang,10 Jianmin Zhuo,11 Cuili Hu11 1Psychiatry Department, Beijing Anding Hospital, Capital Medical University, National Clinical Research Center for Mental Disorders, Beijing, China...
Enregistré dans:
Auteurs principaux: | Wang G, You X, Wang X, Xu X, Bai L, Xie J, Yao Z, Yi Q, Ma J, Wang J, Zhuo J, Hu C |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8cfb2087f7aa4e20b5bef4a44c0f4a04 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
par: Jiang KD, et autres
Publié: (2017) -
Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
par: Xue-Qin Wang, et autres
Publié: (2021) -
Effects of escitalopram with a Chinese traditional compound Jiuweizhenxin-keli on mismatch negativity and P50 in patients with major depressive disorders
par: Kuang W, et autres
Publié: (2016) -
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
par: Kishi T, et autres
Publié: (2017) -
Long-term administration of escitalopram in patients with social anxiety disorder in Japan
par: Asakura S, et autres
Publié: (2016)